Private Company Shares Death UK (2026): What Happens When a Shareholder Dies?

Shares in a private limited company form part of the deceased's estate and pass either under their will or, if there is no will, under the intestacy rules. The executor obtains probate and then deals with the shares according to the terms of the will and the company's articles of association. In most cases the executor is entitled to be registered as the holder of the shares (or to have the shares transmitted to a named beneficiary) — but the company's articles and any shareholders' agreement may impose restrictions on this, including pre-emption rights and compulsory transfer provisions. The company itself does not cease to exist: it continues to trade as normal. The deceased's directorship (if any) terminates automatically on death — a separate appointment process is required for any replacement director.

Yes — shares in a private limited company are personal property and can be left in a will like any other asset. A specific bequest of the shares ('I give my shares in [Company Name] to [Name]') is the clearest approach. Alternatively, shares may pass as part of the residuary estate. The executor must deal with the shares in accordance with the will, the company's articles, and any shareholders' agreement. The key constraint is not the will but the company documentation: the articles may require the executors to offer the shares to existing shareholders before transferring them to a beneficiary, or they may give the company's directors power to refuse registration of a transfer. If a shareholders' agreement includes a cross-option or buy-sell agreement, the surviving shareholders may have an option (or an obligation) to purchase the shares at a pre-agreed or formula-based price, which takes precedence over any specific bequest in the will.

Pre-emption rights (or rights of first refusal) are provisions in a company's articles or shareholders' agreement giving existing shareholders the right to purchase shares before they can be transferred to an outsider. Whether pre-emption rights apply on death depends on how they are drafted: some clauses apply only to voluntary transfers (not to transmission on death); others apply to any transmission, including death. If pre-emption applies on death, the executor must first offer the shares to the existing shareholders at a price determined by the clause (often fair value certified by the company's auditors) before the shares can be transferred to the estate beneficiary. This can create a significant practical problem: the beneficiary named in the will may have expected to receive the shares, but existing shareholders exercise their pre-emption right and instead the estate receives cash. Careful review of the articles before drafting a will is essential for any director-shareholder.

A cross-option agreement (also called a double option or buy-sell agreement) is a contract between the company's shareholders that operates on the death (or sometimes serious illness) of a shareholder. It contains two options: (1) a put option — the deceased's estate has the right to require the surviving shareholders to buy the deceased's shares; and (2) a call option — the surviving shareholders have the right to require the estate to sell the deceased's shares to them. Crucially, neither option is an obligation on its own — either side can choose whether to exercise. This structure is HMRC-approved and (when properly drafted) does not compromise business property relief because the options are not mutual binding contracts that would treat the shares as 'subject to a contract of sale' under IHTA 1984 s.113. The purchase price is typically based on a formula (earnings multiple, net asset value) agreed at the time the cross-option agreement is entered into. Life insurance — one policy on each shareholder's life, written in trust for the other shareholders — provides the cash to fund the purchase without the proceeds forming part of the deceased's estate.

Shares in a private company are unquoted and must be valued at open market value at the date of death. The standard is the price a hypothetical willing buyer would pay a hypothetical willing seller — HMRC Share Valuation (part of the Valuation Office Agency) agrees the value with the executor. Relevant factors include: the company's net assets, earnings, and dividend history; whether the shareholding is a majority (premium over minority) or minority (discount for lack of control); restrictions on transfer in the articles; comparisons with similar quoted companies. Minority discounts of 25–40% are common for non-controlling stakes. The executor must submit the valuation on form IHT400 (and form IHT412 for unlisted shares); HMRC may query or negotiate the value. Where shares qualify for 100% BPR, the agreed value is still needed even though no IHT results from it, because the relief must be formally claimed. Post-death falls in value: if shares are sold within 12 months of death at below probate value, the estate may substitute the sale price as the IHT value (IHTA 1984 s.179 — loss on sale of shares relief).

Yes — unquoted shares in a qualifying company attract 100% business property relief under section 105(1)(bb) of the Inheritance Tax Act 1984, provided: (1) the deceased owned the shares for at least 2 years before death; and (2) the company's business is wholly or mainly trading (not investment). This means the shares are IHT-free at 100%. From 6 April 2026, the combined BPR and APR cap of £1 million at 100% applies — value above that threshold attracts only 50% relief (effective IHT rate 20%). Shares in a company that is wholly or mainly holding investment assets (rental property, financial investments) do not qualify for BPR. Quoted shares on the main stock exchange also do not qualify; AIM-listed shares do qualify, subject to the same trading requirement. Where BPR is denied or partially available, the executor should check whether the shares fall within an excepted asset class (assets surplus to business requirements) — these are excluded from BPR in any event.

A director's appointment terminates automatically on their death — this is a fundamental principle of company law: a director is a natural person and their authority ceases when they cease to exist. The company does not lose its legal status; it continues and the remaining directors (if any) continue to act. If the deceased was a sole director, the company is left without a director. The company cannot take formal board decisions without a director, which can cause serious operational and banking problems. The shareholders (including the executor representing the deceased's shareholding) can pass an ordinary resolution to appoint a new director. If the executor cannot gain the necessary majority to appoint a director, a court application may be needed in extreme cases. Good succession planning for a sole director-shareholder involves: naming a substitute director in writing; ensuring at least one other person has company bank account authority; and addressing the directorship in any shareholders' agreement alongside the share succession provisions.